Please use this identifier to cite or link to this item:
http://10.1.7.192:80/jspui/handle/123456789/5923
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kothari, Charmy | - |
dc.date.accessioned | 2015-08-07T06:04:38Z | - |
dc.date.available | 2015-08-07T06:04:38Z | - |
dc.date.issued | 2011 | - |
dc.identifier.uri | http://hdl.handle.net/123456789/5923 | - |
dc.description | International Journal of Drug Formulation and Research, 2(5); Sep.-Oct. 2011 | en_US |
dc.description.abstract | A simple, precise, accurate and rapid high performance thin layer chromatographic method has been developed and validated for the estimation of atomoxetine Hydrochloride in tablet dosage forms. The stationary phase used was precoated silica gel 60F254. The mobile phase used was a mixture of acetonitrile: methanol: toluene (2:4:1 v/v/v). The detection of spots was carried out at 215 nm. The method was validated in terms of linearity, accuracy, precision, specificity and system suitability. The calibration curve was found to be linear between 100 to 350 ng/spot for atomoxetine hydrochloride. Average percentage recoveries obtained was 101.83 %. The limit of detection and the limit of quantification were found to be 40 and 100 ng/spot, respectively. The proposed method is useful in the quality control of bulk manufacturing and pharmaceutical dosage forms. | en_US |
dc.publisher | IJDFR | en_US |
dc.relation.ispartofseries | IPFP0167 | - |
dc.subject | Atomoxetine hydrochloride | en_US |
dc.subject | HPTLC | en_US |
dc.subject | Method Development | en_US |
dc.subject | Validation | en_US |
dc.title | Development and Validation of HPTLC Method for The Estimation of Atomoxetine Hydrochloride in Tablet Dosage Form | en_US |
dc.type | Faculty Papers | en_US |
Appears in Collections: | Faculty Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
IPFP0167.pdf | IPFP0167 | 300.71 kB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.